Across the United Kingdom, nearly half a million people carry invisible wounds in their hearts—walls thickening, chambers narrowing, all without a single symptom to warn them. Research from Imperial College London, drawing on data from 480,000 adults, has traced this silent damage to chronic inflammation fueled not only by smoking and excess weight, but by poverty, psychological distress, and the quiet burdens of social hardship. The findings remind us that the heart does not exist apart from the life surrounding it, and that what society does to people, the body records in its deepest tissues
Chronic inflammation silently damages hearts years before symptoms emerge, study finds
Millions living with hidden inflammation slowly changing their hearts
So this study tracked nearly half a million people. What exactly were the researchers measuring?
They used a blood marker called glycoprotein acetyls—GlycA—to measure chronic inflammation. Then they matched that against heart imaging and genetic data from the UK Biobank.
And that blood marker is validated? It's not just one lab's proprietary test?
It's established enough that it's being used in large epidemiological studies like this one. But you're right to push—the strength of the finding depends on how well that marker actually captures what matters.
The 43 percent increased risk—that's comparing the highest inflammation group to the lowest?
Yes. Highest versus lowest. And the structural changes they found—thickened walls, smaller chambers, poor filling—those were visible on imaging.
Were those changes present in people without any symptoms? Because that's the real claim here.
That's exactly what they found. Silent structural changes years before cardiovascular symptoms appear.
And what about the social factors? The study linked poverty and mental health to inflammation?
Strong associations, yes. Socioeconomic disadvantage and psychological distress both correlated with higher inflammation levels.
But correlation isn't causation. We don't know if poverty causes inflammation or if the stress response to poverty does, or if there's a third factor.
True. The researchers describe it as a pathway—one way these social stresses might increase cardiovascular risk. But you're right that the mechanism isn't fully established.
What about the genetic piece? How much of this is just luck of the draw?
They found a strong genetic component—some people are naturally more resilient to inflammatory damage. But they were clear that genetics isn't destiny. Lifestyle and circumstances still matter enormously.
And the drugs they mention—the ones targeting interleukin-1 and TNF proteins—are those actually in trials for heart disease prevention, or is that speculative?
They said several are already in clinical trials. But whether they'll actually prevent cardiovascular disease in people with high inflammation is still an open question.
Il Polso
- Nearly half a million people are walking around with measurable structural heart damage they cannot feel, making this a crisis hidden in plain sight.
- Those with the highest inflammation levels face a 43% greater risk of heart attack and stroke—a gap wide enough to reframe how medicine thinks about prevention.
- The inflammation is not random: poverty, mental distress, smoking, and excess body fat all converge to trigger the immune cascade that quietly remodels the heart over years.
- Genetics add another layer of injustice—some people are biologically more vulnerable to the same social and lifestyle pressures, meaning identical hardship can produce vastly different damage.
- Anti-inflammatory drugs targeting interleukin-1 and TNF proteins are already in clinical trials, and pairing inflammation blood tests with genetic risk scores could open a window for intervention before disease ever declares itself.
Across the United Kingdom, nearly half a million people carry invisible wounds in their hearts—walls thickening, chambers narrowing, all without a single symptom to warn them. Research from Imperial College London, drawing on data from 480,000 adults, has traced this silent damage to chronic inflammation fueled not only by smoking and excess weight, but by poverty, psychological distress, and the quiet burdens of social hardship. The findings remind us that the heart does not exist apart from the life surrounding it, and that what society does to people, the body records in its deepest tissues.
Nearly half a million British adults are living with structural heart damage they cannot feel. Their walls are thickening, their chambers shrinking, their hearts filling less efficiently—all driven by chronic inflammation working silently over years. The findings, published in the European Journal of Preventive Cardiology, come from scientists at Imperial College London who analyzed data from 480,000 people in the UK Biobank, measuring inflammation through a blood marker called glycoprotein acetyls and cross-referencing results with heart imaging and genetic data.
The numbers were stark. People with the highest inflammation levels faced a 43 percent greater risk of heart attack and stroke compared to those with the lowest. These structural changes can develop for years without symptoms, potentially progressing toward heart failure before anyone realizes something is wrong.
What surprised even the researchers was how deeply social circumstances and mental health were woven into the inflammatory cascade—alongside the more familiar culprits of smoking and physical inactivity. Socioeconomic hardship and psychological distress proved to be powerful drivers of inflammation, placing the heart squarely within the broader landscape of a person's life conditions. Genetics added further complexity: two people living under identical pressures can experience very different degrees of heart damage depending on their biological susceptibility.
The study identified specific proteins from the interleukin-1 and TNF families as likely agents of the damage, and several drugs targeting these proteins are already in clinical trials. Researchers propose combining inflammation blood tests with genetic risk scores to catch vulnerable individuals before disease takes hold. Yet the scientists were careful to note that neither genetics nor hardship is destiny—much can be done to interrupt the inflammatory process. The work points toward a future where anti-inflammatory medicine becomes a standard preventive tool, while also pressing the harder question of the social and economic conditions that set inflammation in motion to begin with.
Nearly half a million British adults are walking around with invisible damage to their hearts, according to research published this week in the European Journal of Preventive Cardiology. They don't feel it. They have no symptoms. But their heart walls are thickening, their chambers are shrinking, and their hearts are filling less efficiently than they should—all because of chronic inflammation quietly at work in their bodies.
Scientists at Imperial College London and the MRC Laboratory of Medical Sciences analyzed data from 480,000 people in the UK Biobank, using a blood marker called glycoprotein acetyls to measure inflammation levels. They cross-referenced those measurements with heart imaging and genetic information. What they found was stark: people with the highest inflammation levels faced a 43 percent greater risk of heart attack and stroke compared to those with the lowest levels. The structural changes—the thickened walls, the smaller chambers, the sluggish filling—can develop silently for years, potentially progressing to heart failure without anyone knowing anything is wrong.
The inflammation driving this damage doesn't emerge from nowhere. The researchers traced it to a constellation of factors that cluster around disadvantage and stress. Socioeconomic hardship, psychological distress, smoking, and excess body weight all correlate strongly with elevated inflammation. But the study also found something that surprised even the researchers: how tightly mental health and social circumstances bind to the inflammatory cascade. "The surprising thing was how much social factors and mental health are linked to inflammation and damage to the heart—as well as more well-known risk factors like smoking and inactivity," said Declan O'Regan, the British Heart Foundation Chair of Cardiovascular AI at Imperial College London and head of the Computational Cardiac Imaging Group at the MRC Laboratory.
Genetics matter too. Some people are naturally more resilient to the inflammatory damage that comes from stress and poor lifestyle choices, while others are more susceptible. This genetic component means that two people living under identical circumstances can experience very different levels of heart damage. O'Regan put it plainly: "Millions of people could be living with hidden inflammation, which is slowly changing their heart and causing long-term damage—increasing the risk of heart attack and stroke." The inflammation itself is a long-term, low-level activation of the immune system, a condition already linked to cancer and diabetes and increasingly recognized as a driver of cardiovascular disease.
The study identified specific inflammatory proteins—from the interleukin-1 and TNF families—as likely culprits in the heart damage. Several drugs already in clinical trials target these proteins, suggesting that anti-inflammatory treatments might one day prevent cardiovascular disease before symptoms ever surface. The researchers propose that combining inflammation blood tests with genetic risk scores could help identify people who might benefit from early intervention. Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation, emphasized that inflammation plays a darker role alongside its healing function: "This large-scale study found people with higher levels of inflammation experienced silent changes to the structure of their hearts and had a higher risk of major cardiac events."
But the researchers were careful to note that genetic susceptibility or exposure to hardship does not seal a person's fate. Much can be done to prevent long-term inflammation. The findings underscore how genes, lifestyle, smoking, mental health, and socioeconomic status converge to trigger the inflammatory cascade that damages hearts. The work points toward a future where anti-inflammatory medicines become a standard tool in preventing cardiovascular disease—but also toward the harder, slower work of addressing the social and economic conditions that drive inflammation in the first place.
Citazioni salienti
Millions of people could be living with hidden inflammation, which is slowly changing their heart and causing long-term damage—increasing the risk of heart attack and stroke.— Declan O'Regan, British Heart Foundation Chair of Cardiovascular AI at Imperial College London
The surprising thing was how much social factors and mental health are linked to inflammation and damage to the heart—as well as more well-known risk factors like smoking and inactivity.— Declan O'Regan